Clinical Trial Update: Study to Examine the Effects of MultiStem in Ischemic Stroke [Phase 2]

View source ↗

Summary

Completion status update for a Phase 2 trial evaluating MultiStem in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• MultiStem (mesenchymal-like stem cell product)

Snippet

Sponsor: Healios K.K. | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED